App therapy tackles mental health in opioid treatment

NCT ID NCT05047627

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a smartphone app designed to reduce anxiety and depression in people already receiving medication for opioid use disorder. 63 adults were randomly assigned to use the app for four weeks or to continue their usual care. The goal was to see if the app was feasible and acceptable, and to get early data on whether it could improve mental health and reduce opioid cravings and use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Smartphone-based digital intervention (cognitive-behavioral therapy app)
What this could lead to
If it works, this could provide a low-cost, scalable way to treat anxiety and depression in people receiving medication for opioid use disorder, potentially improving overall outcomes.
What could go wrong
This was a small, early feasibility study with only 63 participants and no control for the app's specific effects. The intervention was still being developed, so results may not be generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center For Technology and Behavioral Health

    Lebanon, New Hampshire, 03766, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.